In new case study, CyPath Lung spares elderly woman from an invasive procedure for a suspicious lung nodule discovered on a ...
The FDA has cleared RevealDx’s AI-powered lung nodule risk assessment software, RevealAI-Lung, according to a company press ...
WTKR News 3 Norfolk, VA on MSN
Robotic technology helps doctors reach previously inaccessible lung nodules
None ...
Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and ...
News-Medical.Net on MSN
CNN-based system improves lung nodule detection and classification
Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.
THOMASVILLE — Archbold Pulmonology offers patients state-of-the-art technology with the Intuitive Ion robotic bronchoscopy ...
Noninvasive CyPath® Lung test has shown 92% sensitivity, 87% specificity and 88% accuracy for detecting lung cancer in small nodules less than 2 centimetersCase study highlights how CyPath® Lung ...
In a significant advancement for thoracic oncology within the Appalachian region, WVU Medicine has announced it is the first ...
WVU Medicine pioneers nonthermal PEF therapy for metastatic lung nodules, using robotic bronchoscopy to target tumors precisely and potentially boost immune response.
GlobalData on MSN
FDA clears Median Technologies’ lung nodule evaluation software
Median's eyonis LCS is software is reimbursable under Medicare at a rate between $601 to $700.
Shira Boehler shares her journey being diagnosed with Stage 1 lung cancer. A doctor explains the need for better lung cancer screening for asymptomatic, never smokers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results